Navigation Links
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Date:6/2/2009

EMERYVILLE, Calif., June 2 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the appointment of Klaus Kohl, Ph.D., as Senior Vice President and Chief Technical Officer. Dr. Kohl brings to Bionovo over 20 years of experience in product development and manufacturing. Dr. Kohl will be responsible for manufacturing, quality assurance, and regulatory compliance.

"We are very excited to add Dr. Kohl to our management team," said Isaac Cohen, O.M.D., Bionovo's Chairman and CEO. He added, "We believe Dr. Kohl's extensive background in the pharmaceutical industry will prove invaluable to Bionovo's current efforts. Klaus' two decades of experience and broad knowledge will optimize our organization to meet with partnering and commercialization standards."

Dr. Kohl's most recent position was as Vice President of Program Management, CMC and Regulatory Affairs at Novo Nordisk Delivery Technologies, where he was responsible for the development of an inhaled insulin drug/device combination product. Prior to Novo Nordisk, Dr. Kohl served as Senior Vice President, Quality and Technical Director at Aradigm Corporation, a specialty pharmaceutical development company focused on respiratory disease management.

From 1985 to 2001, Dr. Kohl worked for Bayer Corporation, where he held various executive positions in quality assurance and drug product development. Before Bayer, Dr. Kohl was engaged in basic research for more than seven years at the Juelich Research Center in Germany, and the Max Planck Institute in Dortmund, Germany.

Dr. Kohl holds an undergraduate degree in Mathematics and Physics from the University of Marburg, Germany, and a master's degree in Experimental Physics and Ph.D. in Biophysics from the University of Aachen, Germany.

Dr. Kohl states, "I feel I am joining
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108
2. Bionovo Announces 2008 Highlights and Year-End Financial Results
3. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
4. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
5. Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform
6. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
7. Bionovo to Present at the Piper Jaffray Healthcare Conference
8. Ethan Weiss, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Reports Third Quarter 2008 Financial Results
10. Bionovo to Present at Merriman Curhan Fords Investor Summit 2008 on September 15th
11. Bionovo to Present at Canaccord Adams Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Mapp Biopharmaceutical,s valiant effort ... therapeutic to fight the Ebola outbreak will make ... the production of pharmaceuticals can be, according to ... that while some may be taken aback by ... with industry knowledge are well aware of the ...
(Date:10/20/2014)... -- GenVec, Inc. (NASDAQ: GNVC ) today announced the ... board of directors effective on October 24, 2014.   Dr. Horovitz ... its chairman from June 2006 to November 2013.  During his ... and Audit Committees of the board.  "We ... service to GenVec, and its stockholders," said Wayne T. ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The Latin ... the market in Latin America with analysis and forecast ... in 2013, and is expected to reach $2,366.8 million ... to 2018. , Browse through the TOC of the ... idea of the in-depth analysis provided. It also provides ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report defines ... analysis and forecast of revenue. This market is estimated ... million by 2019, at a Compound Annual Growth Rate ... through the TOC of the Asia-Pacific Speech Analytics market ... provided. It also provides a glimpse of the segmentation ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Zola P. Horovitz To Retire From GenVec Board 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
... in Diversity, Military and Campus Recruitment, and Employment Branding joins Pierpoint ... ... San Jose, CA (PRWEB) October 20, 2008 -- Pierpoint ... Vice President of Recruitment Operations and Diversity. Mr. Cantu, most recently ...
... SETAUKET, N.Y., Oct. 20 John S. Kovach,M.D., ... Biotechnology Holdings,Inc. (OTC Bulletin Board: LIXT), announces the ... of Directors., Dr. Sorensen is currently Board ... He is a highly experienced leader and,administrator in ...
... announced today that the Company will host an investor ... PM Eastern Time to present an,analysis of the data ... IT-R-006) for the treatment of nasolabial folds, or,wrinkles. On ... results from these two studies, which met all primary ...
Cached Biology Technology:Robert Cantu Appointed Vice President of Pierpoint International 2Lixte Biotechnology Holdings Announces New Appointment to Board of Directors 2Lixte Biotechnology Holdings Announces New Appointment to Board of Directors 3Lixte Biotechnology Holdings Announces New Appointment to Board of Directors 4Isolagen to Host Investor Conference Call to Present an Analysis of the Data from Phase III Wrinkle Studies 2
(Date:10/17/2014)... Accurate knowledge regarding Ebola is critical and pertinent for ... hazardous global outbreak and epidemic. The Journal, Disaster ... special issue, Ebola Virus and Public Health, to surround ... in this critical societal moment. , On October ... for Clinicians . The primer was prepared by Dr. ...
(Date:10/17/2014)... is available in German . ... very few drugs. When treating overdoses, doctors are often limited ... difficult if there is a combination of drugs involved. So ... accidentally swallows his grandmother,s pills? ETH professor Jean-Christophe Leroux from ... find an answer to this question. "The task was to ...
(Date:10/16/2014)... land managers have a new synthesis of recent research ... (MMC) forests in the two states. , The ... Oregon and Washington: A Synthesis of the Relevant Biophysical ... technical report published by the U.S. Forest Service,s Pacific ... request from managers for a synthesis of the large ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
... The National Space Biomedical Research Institute (NSBRI) has renewed awards ... the Massachusetts Institute of Technology and Texas A&M University. In ... to work toward a Ph.D. that focuses specifically on space ... million over a five-year period. "MIT and Texas ...
... University of Illinois at Chicago has been awarded a ... community-based health promotion programs for older adults with osteoarthritis. ... on Aging. The study will compare Fit and ... program, with Fit and Strong! Plus, the traditional program ...
... Clemson University researchers are teaming up with Coastal ... of sensors along the Savannah River to gather data ... will collect and transmit real-time information about the quality ... Intelligent River project leaders Gene Eidson, director of Clemson,s ...
Cached Biology News:NSBRI renews space life sciences graduate programs at MIT, Texas A&M 2UIC study examines exercise and weight loss for older adults with osteoarthritis 2UIC study examines exercise and weight loss for older adults with osteoarthritis 3Clemson, Coastal Carolina universities to set hundreds of sensors in Savannah River 2
... CL3 series is designed to enhance ... clinical applications at a reasonable cost. ... quick connect rotors and various biocontainment ... interface allows you to control and ...
PP2B-Abeta (C-20)...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
... a fully licensed, high throughput, water bath thermal ... to 24 microplates. This equates to 9,216 reactions ... A robotic arm rapidly transfers a basket of ... ramping times that are considerably faster than those ...
Biology Products: